PureTech Health plc
PRTC
$17.74
$1.086.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 542.71% | 542.71% | 2,422.22% | 2,422.22% | -90.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 542.71% | 542.71% | 2,422.22% | 2,422.22% | -90.86% |
| Cost of Revenue | -36.04% | -36.04% | -27.56% | -27.56% | -26.75% |
| Gross Profit | 40.35% | 40.35% | 38.15% | 38.15% | 22.71% |
| SG&A Expenses | -10.36% | -10.36% | 61.12% | 61.12% | 6.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.35% | -25.35% | 7.33% | 7.33% | -15.92% |
| Operating Income | 27.81% | 27.81% | -1.01% | -1.01% | 12.82% |
| Income Before Tax | 20.30% | 20.30% | 452.44% | 452.44% | -300.43% |
| Income Tax Expenses | 115.02% | 115.02% | -88.57% | -88.57% | -152.06% |
| Earnings from Continuing Operations | 8.39% | 8.39% | 286.64% | 286.64% | -91.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -97.52% | -97.52% | 4,735.58% | 4,735.58% | 1,202.38% |
| Net Income | -6.78% | -6.78% | 334.15% | 334.15% | -67.07% |
| EBIT | 27.81% | 27.81% | -1.01% | -1.01% | 12.82% |
| EBITDA | 28.40% | 28.40% | -1.88% | -2.23% | 11.65% |
| EPS Basic | -19.87% | -19.87% | 368.33% | 368.33% | -72.61% |
| Normalized Basic EPS | 15.43% | 15.43% | 35.67% | 35.67% | 19.93% |
| EPS Diluted | -22.58% | -22.58% | 358.38% | 358.38% | -72.22% |
| Normalized Diluted EPS | 15.43% | 15.43% | 36.43% | 36.43% | 19.93% |
| Average Basic Shares Outstanding | -11.01% | -11.01% | -12.79% | -12.79% | -3.09% |
| Average Diluted Shares Outstanding | -11.01% | -11.01% | -11.65% | -11.65% | -3.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |